Brief: Sareum Holdings Announces Commencement Of A Phase 1a Clinical Trial For SDC-1801

Sareum Holdings

18/05/2023 07:32

May 18 (Reuters) - Sareum Holdings PLC  SAR.L :
    * SAREUM HOLDINGS PLC - PHASE 1B CLINICAL STUDY OF SDC-1801
IS
EXPECTED TO COMMENCE IN PSORIASIS PATIENTS IN 2024
    * SAREUM HOLDINGS PLC  - PHASE 1A CLINICAL TRIAL FOR
SDC-1801

Further company coverage:  SAR.L 

 ((Reuters.Briefs@thomsonreuters.com;))